Abbvie Inc. vs HCA Healthcare, Inc.
ABBV vs HCA — side-by-side comparison from reported financials. ABBV leads 4, HCA leads 6 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
HCA Healthcare, Inc.
HCA · Healthcare
$445.04+0.01%Strained
| Metric | ABBV | HCA |
|---|---|---|
| Price | $276.43 | $445.04 |
| Market cap | $488B | $96.3B |
| Revenue (TTM) | $64.4B | $78.0B |
| Revenue growth | +1.8% | +7.9% |
| Net margin | 9.8% | 8.8% |
| Free cash flow | $18.2B | $6.00B |
| Net cash (debt) | ($56.2B) | ($45.5B) |
| 1-year price return | +19.8% | +6.2% |
| P/E | 77.4 | 14.3 |
| P/E vs own history (cheap-side %) | 23% | 44% |
| Dividend yield | 2.45% | 0.70% |
| Return on equity | 96% | 696% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 57,000 | 320,000 |
Full résumé-style profiles: ABBV CV · HCA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.